J&J’s prostate cancer drug Zytiga is effective in slowing down the prostate cancer
Johnson & Johnson’s (J&J’s) Zytiga (abiraterone acetate), a drug used for prostate cancer, has significantly decreased the progression of the
Read MoreStarting from science and ending nowhere…
Johnson & Johnson’s (J&J’s) Zytiga (abiraterone acetate), a drug used for prostate cancer, has significantly decreased the progression of the
Read MoreU.S. Food and Drug Administration (FDA) has voted against the new use of the Johnson & Johnson (J&J) and Bayer’s
Read MoreJohnson and Johnson (J&J) have released the reports of its 2012 First-Quarter results. According to the report, first quarter profit
Read MoreBristol Myers Squibb (BMS) Co. and Johnson & Johnson (J&J) have plans to work together in order to develop medicine
Read More